Your browser doesn't support javascript.
loading
The association of sensitivity and specificity with disease prevalence: analysis of 6909 studies of diagnostic test accuracy.
Murad, M Hassan; Lin, Lifeng; Chu, Haitao; Hasan, Bashar; Alsibai, Reem A; Abbas, Alzhraa S; Mustafa, Reem A; Wang, Zhen.
Afiliación
  • Murad MH; Evidence-Based Practice Center (Murad, Hasan, Alsibai, Abbas, Wang), Mayo Clinic, Rochester, Minn.; Department of Epidemiology and Biostatistics (Lin), University of Arizona, Tucson, Ariz.; Statistical Research and Data Science Center (Chu), Pfizer, New York, NY; Department of Internal Medicine (Mus
  • Lin L; Evidence-Based Practice Center (Murad, Hasan, Alsibai, Abbas, Wang), Mayo Clinic, Rochester, Minn.; Department of Epidemiology and Biostatistics (Lin), University of Arizona, Tucson, Ariz.; Statistical Research and Data Science Center (Chu), Pfizer, New York, NY; Department of Internal Medicine (Mus
  • Chu H; Evidence-Based Practice Center (Murad, Hasan, Alsibai, Abbas, Wang), Mayo Clinic, Rochester, Minn.; Department of Epidemiology and Biostatistics (Lin), University of Arizona, Tucson, Ariz.; Statistical Research and Data Science Center (Chu), Pfizer, New York, NY; Department of Internal Medicine (Mus
  • Hasan B; Evidence-Based Practice Center (Murad, Hasan, Alsibai, Abbas, Wang), Mayo Clinic, Rochester, Minn.; Department of Epidemiology and Biostatistics (Lin), University of Arizona, Tucson, Ariz.; Statistical Research and Data Science Center (Chu), Pfizer, New York, NY; Department of Internal Medicine (Mus
  • Alsibai RA; Evidence-Based Practice Center (Murad, Hasan, Alsibai, Abbas, Wang), Mayo Clinic, Rochester, Minn.; Department of Epidemiology and Biostatistics (Lin), University of Arizona, Tucson, Ariz.; Statistical Research and Data Science Center (Chu), Pfizer, New York, NY; Department of Internal Medicine (Mus
  • Abbas AS; Evidence-Based Practice Center (Murad, Hasan, Alsibai, Abbas, Wang), Mayo Clinic, Rochester, Minn.; Department of Epidemiology and Biostatistics (Lin), University of Arizona, Tucson, Ariz.; Statistical Research and Data Science Center (Chu), Pfizer, New York, NY; Department of Internal Medicine (Mus
  • Mustafa RA; Evidence-Based Practice Center (Murad, Hasan, Alsibai, Abbas, Wang), Mayo Clinic, Rochester, Minn.; Department of Epidemiology and Biostatistics (Lin), University of Arizona, Tucson, Ariz.; Statistical Research and Data Science Center (Chu), Pfizer, New York, NY; Department of Internal Medicine (Mus
  • Wang Z; Evidence-Based Practice Center (Murad, Hasan, Alsibai, Abbas, Wang), Mayo Clinic, Rochester, Minn.; Department of Epidemiology and Biostatistics (Lin), University of Arizona, Tucson, Ariz.; Statistical Research and Data Science Center (Chu), Pfizer, New York, NY; Department of Internal Medicine (Mus
CMAJ ; 195(27): E925-E931, 2023 07 17.
Article en En | MEDLINE | ID: mdl-37460126
ABSTRACT

BACKGROUND:

Sensitivity and specificity are characteristics of a diagnostic test and are not expected to change as the prevalence of the target condition changes. We sought to evaluate the association between prevalence and changes in sensitivity and specificity.

METHODS:

We retrieved data from meta-analyses of diagnostic test accuracy published in the Cochrane Database of Systematic Reviews (2003-2020). We used mixed-effects random-intercept linear regression models to evaluate the association between prevalence and logit-transformed sensitivity and specificity. The model evaluated all meta-analyses as nested within each systematic review.

RESULTS:

We analyzed 6909 diagnostic test accuracy studies from 552 meta-analyses that were included in 92 systematic reviews. For sensitivity, compared with the lowest quartile of prevalence, the second, third and fourth quartiles were associated with significantly higher odds of identifying a true positive case (odds ratio [OR] 1.17, 95% confidence interval [CI] 1.09-1.26; OR 1.32, 95% CI 1.23-1.41; OR 1.47, 95% CI 1.37-1.58; respectively). For specificity, compared with the lowest quartile of prevalence, the second, third and fourth quartiles were associated with significantly lower odds of identifying a true negative case (OR 0.74, 95% CI 0.69-0.80; OR 0.65, 95% CI 0.60-0.70; OR 0.47, 95% CI 0.44-0.51; respectively). Pooled regression coefficients from bivariate models conducted within each meta-analysis showed that prevalence was positively associated with sensitivity and negatively associated with specificity. Findings were consistent across subgroups.

INTERPRETATION:

In this large sample of diagnostic studies, higher prevalence was associated with higher estimated sensitivity and lower estimated specificity. Clinicians should consider the implications of disease prevalence and spectrum when interpreting the results from studies of diagnostic test accuracy.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas Diagnósticas de Rutina Tipo de estudio: Clinical_trials / Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: CMAJ Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas Diagnósticas de Rutina Tipo de estudio: Clinical_trials / Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: CMAJ Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article